Sign up
ENLV

Enlivex Therapeutics Ltd (NASDAQ: ENLV)

Healthcare · Biotechnology

$1.20

Last close · Nov 18, 2026 · NASDAQ USD

Set alert

The Quantellect read. Short interest is 5.51% of float with a 87.09% borrow fee. Two active firms cover the stock as of Nov 19, 2026; one active firm with a target averages $80.00 over 12 months, and the next earnings report is due Nov 20, 2026. Descriptive summary of the data on this page, not a recommendation.

Relative valuationLower multiples than peers

P/B 0.0× vs peer median 2.6×

Momentum—

—

TrendBelow both averages

$1.20 vs $5.44 and $123.01 · as of Nov 18, 2026

Short interest5.5% of float

FINRA settlement Oct 30, 2026

ENLV price chart

Price $1.20 · As of Nov 18, 2026, 8:42 PM ET

Open full chart →
Nov 18, 2026O $1.18H $1.29L $1.16C $1.20Vol 39K

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First dateMay 18, 2026 ET
Last dateNov 18, 2026 ET
Open$175.20
High$215.86
Low$1.00
Close$1.20
Volume87,322,271
Plotted bars129

Plotted OHLCV bars

  1. May 18, 2026 ET · Open $175.20 · High $177.58 · Low $165.65 · Close $167.35 · Volume 125,207
  2. May 19, 2026 ET · Open $165.60 · High $171.65 · Low $165.60 · Close $169.08 · Volume 97,621
  3. May 20, 2026 ET · Open $167.04 · High $172.82 · Low $165.70 · Close $168.84 · Volume 134,828
  4. May 21, 2026 ET · Open $170.62 · High $176.64 · Low $165.74 · Close $172.85 · Volume 126,918
  5. May 22, 2026 ET · Open $176.88 · High $178.27 · Low $171.67 · Close $172.20 · Volume 111,983
  6. May 26, 2026 ET · Open $165.84 · High $168.00 · Low $158.40 · Close $164.16 · Volume 594,142
  7. May 27, 2026 ET · Open $179.76 · High $201.60 · Low $172.80 · Close $187.68 · Volume 1,328,024
  8. May 28, 2026 ET · Open $199.54 · High $199.92 · Low $179.28 · Close $183.46 · Volume 1,095,164
  9. May 29, 2026 ET · Open $190.80 · High $199.73 · Low $182.64 · Close $194.47 · Volume 754,728
  10. Jun 1, 2026 ET · Open $187.20 · High $207.60 · Low $187.20 · Close $207.22 · Volume 813,197
  11. Jun 2, 2026 ET · Open $208.80 · High $215.86 · Low $197.04 · Close $203.98 · Volume 701,795
  12. Jun 3, 2026 ET · Open $199.20 · High $205.10 · Low $197.09 · Close $204.00 · Volume 490,862
  13. Jun 4, 2026 ET · Open $199.92 · High $205.20 · Low $182.40 · Close $189.72 · Volume 384,439
  14. Jun 5, 2026 ET · Open $187.08 · High $187.20 · Low $168.24 · Close $170.40 · Volume 307,720
  15. Jun 8, 2026 ET · Open $172.54 · High $189.60 · Low $171.36 · Close $171.41 · Volume 114,037
  16. Jun 9, 2026 ET · Open $173.88 · High $180.91 · Low $163.44 · Close $166.22 · Volume 355,537
  17. Jun 10, 2026 ET · Open $169.54 · High $170.33 · Low $158.57 · Close $161.42 · Volume 296,392
  18. Jun 11, 2026 ET · Open $165.36 · High $172.56 · Low $158.40 · Close $172.56 · Volume 184,614
  19. Jun 12, 2026 ET · Open $175.20 · High $176.40 · Low $160.80 · Close $160.82 · Volume 180,138
  20. Jun 15, 2026 ET · Open $169.75 · High $169.75 · Low $156.00 · Close $158.42 · Volume 306,140
  21. Jun 16, 2026 ET · Open $161.76 · High $166.15 · Low $149.09 · Close $151.25 · Volume 310,484
  22. Jun 17, 2026 ET · Open $160.49 · High $160.78 · Low $148.32 · Close $148.32 · Volume 267,485
  23. Jun 18, 2026 ET · Open $153.60 · High $155.16 · Low $146.54 · Close $149.21 · Volume 323,676
  24. Jun 22, 2026 ET · Open $151.27 · High $158.40 · Low $142.27 · Close $149.52 · Volume 1,068,931
  25. Jun 23, 2026 ET · Open $144.00 · High $150.60 · Low $142.27 · Close $146.59 · Volume 268,117
  26. Jun 24, 2026 ET · Open $146.62 · High $148.44 · Low $142.56 · Close $145.22 · Volume 309,573
  27. Jun 25, 2026 ET · Open $146.40 · High $150.96 · Low $136.32 · Close $139.32 · Volume 498,151
  28. Jun 26, 2026 ET · Open $139.32 · High $144.00 · Low $133.20 · Close $136.80 · Volume 218,229
  29. Jun 29, 2026 ET · Open $137.02 · High $144.00 · Low $135.10 · Close $139.20 · Volume 224,219
  30. Jun 30, 2026 ET · Open $141.60 · High $141.60 · Low $128.83 · Close $131.98 · Volume 382,620
  31. Jul 1, 2026 ET · Open $141.60 · High $141.60 · Low $125.90 · Close $129.98 · Volume 688,031
  32. Jul 2, 2026 ET · Open $129.70 · High $137.98 · Low $124.80 · Close $126.62 · Volume 569,844
  33. Jul 6, 2026 ET · Open $127.20 · High $129.84 · Low $122.14 · Close $122.90 · Volume 372,690
  34. Jul 7, 2026 ET · Open $116.88 · High $123.36 · Low $109.63 · Close $118.56 · Volume 1,150,338
  35. Jul 8, 2026 ET · Open $113.52 · High $119.74 · Low $102.65 · Close $115.32 · Volume 820,597
  36. Jul 9, 2026 ET · Open $109.76 · High $122.24 · Low $108.80 · Close $118.40 · Volume 98,161
  37. Jul 10, 2026 ET · Open $118.40 · High $118.40 · Low $104.16 · Close $109.76 · Volume 96,541
  38. Jul 13, 2026 ET · Open $117.44 · High $119.00 · Low $104.64 · Close $106.72 · Volume 99,367
  39. Jul 14, 2026 ET · Open $106.24 · High $106.24 · Low $94.72 · Close $96.80 · Volume 51,991
  40. Jul 15, 2026 ET · Open $96.16 · High $98.72 · Low $86.48 · Close $93.44 · Volume 117,038
  41. Jul 16, 2026 ET · Open $94.08 · High $94.72 · Low $75.76 · Close $76.00 · Volume 224,565
  42. Jul 17, 2026 ET · Open $75.52 · High $79.84 · Low $69.12 · Close $74.88 · Volume 118,202
  43. Jul 20, 2026 ET · Open $75.36 · High $77.28 · Low $68.00 · Close $74.24 · Volume 97,372
  44. Jul 21, 2026 ET · Open $73.92 · High $81.28 · Low $71.84 · Close $75.68 · Volume 60,631
  45. Jul 22, 2026 ET · Open $74.40 · High $77.28 · Low $72.56 · Close $73.36 · Volume 65,643
  46. Jul 23, 2026 ET · Open $72.32 · High $73.75 · Low $68.80 · Close $69.76 · Volume 130,572
  47. Jul 24, 2026 ET · Open $69.76 · High $71.52 · Low $65.28 · Close $67.20 · Volume 106,558
  48. Jul 27, 2026 ET · Open $67.52 · High $69.12 · Low $64.32 · Close $68.16 · Volume 59,358
  49. Jul 28, 2026 ET · Open $52.16 · High $52.16 · Low $33.28 · Close $35.84 · Volume 4,001,017
  50. Jul 29, 2026 ET · Open $36.64 · High $37.12 · Low $32.00 · Close $36.00 · Volume 372,687
  51. Jul 30, 2026 ET · Open $36.00 · High $36.00 · Low $30.72 · Close $31.20 · Volume 318,164
  52. Jul 31, 2026 ET · Open $30.56 · High $34.56 · Low $28.80 · Close $33.44 · Volume 341,876
  53. Aug 3, 2026 ET · Open $34.24 · High $37.17 · Low $33.76 · Close $34.72 · Volume 273,264
  54. Aug 4, 2026 ET · Open $36.00 · High $36.08 · Low $32.48 · Close $33.76 · Volume 467,428
  55. Aug 5, 2026 ET · Open $33.12 · High $36.16 · Low $31.68 · Close $34.88 · Volume 286,677
  56. Aug 6, 2026 ET · Open $34.40 · High $35.04 · Low $30.72 · Close $31.68 · Volume 202,970
  57. Aug 7, 2026 ET · Open $31.68 · High $34.19 · Low $30.40 · Close $33.28 · Volume 202,031
  58. Aug 10, 2026 ET · Open $32.32 · High $34.08 · Low $31.12 · Close $32.16 · Volume 190,278
  59. Aug 11, 2026 ET · Open $32.32 · High $33.51 · Low $30.24 · Close $30.72 · Volume 185,624
  60. Aug 12, 2026 ET · Open $32.00 · High $34.88 · Low $27.52 · Close $29.44 · Volume 644,013
  61. Aug 13, 2026 ET · Open $31.04 · High $31.68 · Low $26.88 · Close $27.04 · Volume 451,640
  62. Aug 14, 2026 ET · Open $27.36 · High $27.36 · Low $24.48 · Close $25.28 · Volume 342,396
  63. Aug 17, 2026 ET · Open $25.44 · High $25.92 · Low $24.64 · Close $25.28 · Volume 174,790
  64. Aug 18, 2026 ET · Open $25.12 · High $25.28 · Low $23.68 · Close $24.32 · Volume 148,019
  65. Aug 19, 2026 ET · Open $24.00 · High $28.96 · Low $23.52 · Close $27.68 · Volume 295,095
  66. Aug 20, 2026 ET · Open $26.88 · High $27.20 · Low $23.28 · Close $24.00 · Volume 270,877
  67. Aug 21, 2026 ET · Open $23.84 · High $24.32 · Low $22.24 · Close $23.52 · Volume 157,528
  68. Aug 24, 2026 ET · Open $23.68 · High $24.96 · Low $23.04 · Close $24.16 · Volume 148,740
  69. Aug 25, 2026 ET · Open $23.84 · High $25.12 · Low $23.36 · Close $24.32 · Volume 162,429
  70. Aug 26, 2026 ET · Open $24.32 · High $25.92 · Low $23.36 · Close $24.24 · Volume 149,873
  71. Aug 27, 2026 ET · Open $24.16 · High $26.56 · Low $23.52 · Close $23.60 · Volume 519,248
  72. Aug 28, 2026 ET · Open $24.00 · High $25.20 · Low $21.52 · Close $21.60 · Volume 531,304
  73. Aug 31, 2026 ET · Open $21.28 · High $21.44 · Low $18.40 · Close $20.48 · Volume 403,712
  74. Sep 1, 2026 ET · Open $20.32 · High $20.96 · Low $19.20 · Close $20.48 · Volume 343,342
  75. Sep 2, 2026 ET · Open $20.64 · High $20.80 · Low $19.36 · Close $20.00 · Volume 227,500
  76. Sep 3, 2026 ET · Open $20.00 · High $20.40 · Low $18.08 · Close $18.56 · Volume 293,981
  77. Sep 4, 2026 ET · Open $18.40 · High $18.56 · Low $16.32 · Close $17.60 · Volume 252,141
  78. Sep 8, 2026 ET · Open $17.60 · High $19.04 · Low $16.96 · Close $17.76 · Volume 190,497
  79. Sep 9, 2026 ET · Open $17.92 · High $19.47 · Low $16.32 · Close $16.64 · Volume 287,775
  80. Sep 10, 2026 ET · Open $16.48 · High $16.96 · Low $15.68 · Close $15.69 · Volume 281,540
  81. Sep 11, 2026 ET · Open $16.00 · High $17.12 · Low $15.20 · Close $15.35 · Volume 255,984
  82. Sep 14, 2026 ET · Open $15.20 · High $16.32 · Low $13.82 · Close $13.83 · Volume 304,529
  83. Sep 15, 2026 ET · Open $14.08 · High $14.72 · Low $13.92 · Close $14.12 · Volume 229,436
  84. Sep 16, 2026 ET · Open $14.40 · High $14.72 · Low $12.64 · Close $12.98 · Volume 410,625
  85. Sep 17, 2026 ET · Open $13.14 · High $13.62 · Low $10.24 · Close $11.64 · Volume 767,716
  86. Sep 18, 2026 ET · Open $11.68 · High $13.10 · Low $11.37 · Close $12.91 · Volume 350,080
  87. Sep 21, 2026 ET · Open $13.44 · High $13.60 · Low $10.64 · Close $11.08 · Volume 671,041
  88. Sep 22, 2026 ET · Open $11.04 · High $11.34 · Low $9.18 · Close $10.34 · Volume 1,234,281
  89. Sep 23, 2026 ET · Open $10.13 · High $11.00 · Low $9.84 · Close $10.24 · Volume 594,238
  90. Sep 24, 2026 ET · Open $10.14 · High $10.24 · Low $9.12 · Close $9.69 · Volume 381,202
  91. Sep 25, 2026 ET · Open $9.60 · High $9.92 · Low $9.28 · Close $9.56 · Volume 317,470
  92. Sep 28, 2026 ET · Open $9.60 · High $9.60 · Low $8.04 · Close $8.22 · Volume 631,015
  93. Sep 29, 2026 ET · Open $8.32 · High $8.48 · Low $7.52 · Close $7.68 · Volume 587,736
  94. Sep 30, 2026 ET · Open $7.70 · High $9.28 · Low $7.52 · Close $8.04 · Volume 972,230
  95. Oct 1, 2026 ET · Open $7.87 · High $8.03 · Low $6.58 · Close $6.76 · Volume 756,685
  96. Oct 2, 2026 ET · Open $6.79 · High $6.88 · Low $6.08 · Close $6.20 · Volume 631,111
  97. Oct 5, 2026 ET · Open $6.40 · High $6.53 · Low $5.77 · Close $5.79 · Volume 424,597
  98. Oct 6, 2026 ET · Open $5.98 · High $6.05 · Low $5.44 · Close $5.44 · Volume 409,578
  99. Oct 7, 2026 ET · Open $5.62 · High $5.63 · Low $4.80 · Close $4.90 · Volume 3,898,842
  100. Oct 8, 2026 ET · Open $5.31 · High $6.88 · Low $4.08 · Close $4.43 · Volume 32,680,750
  101. Oct 9, 2026 ET · Open $4.00 · High $4.52 · Low $3.58 · Close $4.06 · Volume 2,783,751
  102. Oct 12, 2026 ET · Open $4.16 · High $4.21 · Low $3.93 · Close $4.05 · Volume 892,924
  103. Oct 13, 2026 ET · Open $4.14 · High $4.15 · Low $3.54 · Close $3.56 · Volume 873,964
  104. Oct 14, 2026 ET · Open $3.60 · High $3.65 · Low $3.36 · Close $3.45 · Volume 557,078
  105. Oct 15, 2026 ET · Open $3.52 · High $3.77 · Low $3.36 · Close $3.59 · Volume 560,327
  106. Oct 16, 2026 ET · Open $3.68 · High $3.73 · Low $3.27 · Close $3.28 · Volume 479,694
  107. Oct 19, 2026 ET · Open $3.38 · High $3.64 · Low $3.08 · Close $3.32 · Volume 607,437
  108. Oct 20, 2026 ET · Open $3.44 · High $3.67 · Low $3.28 · Close $3.58 · Volume 447,511
  109. Oct 21, 2026 ET · Open $3.57 · High $3.68 · Low $3.20 · Close $3.24 · Volume 745,640
  110. Oct 22, 2026 ET · Open $3.14 · High $3.28 · Low $3.08 · Close $3.19 · Volume 525,110
  111. Oct 23, 2026 ET · Open $2.70 · High $2.93 · Low $2.70 · Close $2.77 · Volume 658,993
  112. Oct 26, 2026 ET · Open $2.77 · High $2.80 · Low $2.56 · Close $2.60 · Volume 423,726
  113. Oct 27, 2026 ET · Open $2.56 · High $2.89 · Low $2.22 · Close $2.70 · Volume 80,222
  114. Oct 28, 2026 ET · Open $2.71 · High $2.77 · Low $2.55 · Close $2.61 · Volume 36,323
  115. Oct 29, 2026 ET · Open $2.62 · High $2.76 · Low $2.46 · Close $2.54 · Volume 49,834
  116. Oct 30, 2026 ET · Open $2.47 · High $2.47 · Low $1.73 · Close $1.78 · Volume 128,298
  117. Nov 2, 2026 ET · Open $1.87 · High $1.87 · Low $1.40 · Close $1.41 · Volume 137,600
  118. Nov 3, 2026 ET · Open $1.43 · High $1.56 · Low $1.43 · Close $1.46 · Volume 37,948
  119. Nov 4, 2026 ET · Open $1.44 · High $1.46 · Low $1.37 · Close $1.39 · Volume 24,093
  120. Nov 5, 2026 ET · Open $1.38 · High $1.40 · Low $1.22 · Close $1.27 · Volume 47,035
  121. Nov 6, 2026 ET · Open $1.27 · High $1.30 · Low $1.23 · Close $1.27 · Volume 18,131
  122. Nov 9, 2026 ET · Open $1.28 · High $1.41 · Low $1.28 · Close $1.37 · Volume 20,885
  123. Nov 10, 2026 ET · Open $1.35 · High $1.35 · Low $1.20 · Close $1.20 · Volume 47,130
  124. Nov 11, 2026 ET · Open $1.20 · High $1.27 · Low $1.18 · Close $1.26 · Volume 41,360
  125. Nov 12, 2026 ET · Open $1.25 · High $1.34 · Low $1.19 · Close $1.25 · Volume 20,750
  126. Nov 13, 2026 ET · Open $1.30 · High $1.31 · Low $1.18 · Close $1.19 · Volume 22,312
  127. Nov 16, 2026 ET · Open $1.09 · High $1.13 · Low $1.00 · Close $1.12 · Volume 65,950
  128. Nov 17, 2026 ET · Open $1.15 · High $1.18 · Low $1.11 · Close $1.15 · Volume 18,949
  129. Nov 18, 2026 ET · Open $1.18 · High $1.29 · Low $1.16 · Close $1.20 · Volume 39,224

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of Nov 18, 2026, 8:42 PM ET

Initial 6M price range summary
Range6M
First close$167.35
Last close$1.20
High$215.86
Low$1.00
Volume87,322,271
Open
$1.18Historical · Nov 18, 2026
Previous close
$1.15Nov 17, 2026 close
Day range
$1.16 – $1.29Historical · Nov 18, 2026
52-week range
$0.17 – $7.41Through Nov 18, 2026
Volume
39.22KHistorical · Nov 18, 2026
Average volume (30 calendar days, 22 sessions)
165.32KThrough Nov 18, 2026
Market cap$1.82M
P/E (TTM)0.0
Forward P/E—
EPS (TTM)suspected valuation scale error —
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)0.74

Price history

ENLV · NASDAQ · USD

Split-adjusted · volume in shares

Price history unavailable

Notable price movement

Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.

  1. $1.20−12.41%

    Trading volume was 0.1 times the 30-day average, with 47.13K shares traded.

  2. $1.41−20.79%

    Trading volume was 0.1 times the 30-day average, with 137.6K shares traded.

  3. $1.78−29.92%

    Trading volume was 0.1 times the 30-day average, with 128.3K shares traded.

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide19Low Tide—
Squeeze22Idle—
How the scores work →

How ENLV compares with its industry

Against 592 other US-listed Biotechnology stocks

Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%

Strongest points

  1. Trailing-year return on equity was 162.9%, higher than 100% of 554 peers.Peer median −68.0% · As of Nov 17, 2026
  2. Current ratio was 193.24, higher than 100% of 498 peers.Peer median 4.99 · As of Nov 17, 2026
  3. Six-month return was 70.6%, higher than 93% of 545 peers.Peer median −26.7% · As of Nov 17, 2026

Points of caution

  1. One-month return was -66.5%, with only 3% of 567 peers reporting a lower value.Peer median −13.8% · As of Nov 17, 2026
  2. Trailing-year net margin was 0%, with only 19% of 583 peers reporting a lower value.Peer median 0.0% · As of Nov 17, 2026

Valuation

Lower multiples than peers

  • Price/sales—13.88×

    Not ranked: only 408 of 592 peers report it

  • Forward P/E—14.90×

    Not ranked: only 194 of 592 peers report it

  • Price/book0.00×2.58×
    Lowest of 551 peers

    Higher than 0% of 551 peers

Profitability

Profitability metrics are mixed versus peers.

  • Gross margin—78.4%

    Not ranked: only 247 of 592 peers report it

  • Operating margin0.0%0.0%

    Higher than 26% of 442 peers

  • Net margin0.0%0.0%

    Higher than 19% of 583 peers

  • Return on equity162.9%−68.0%
    Highest of 554 peers

    Higher than 100% of 554 peers

Growth

Growth metrics are lower than most peers.

  • Quarterly sales growth, year over year0.0%0.0%

    Higher than 32% of 592 peers

  • 5-year sales growth rate—11.3%

    Not ranked: only 140 of 592 peers report it

Balance sheet

Balance sheet metrics are higher than most peers.

  • Current ratio193.244.99
    Highest of 498 peers

    Higher than 100% of 498 peers

  • Debt/equity (total borrowings)—0.23

    Not ranked: only 117 of 592 peers report it

Momentum

Returns are higher than most peers.

  • 1-year return+23.1%−28.4%

    Higher than 77% of 522 peers

  • 6-month return+70.6%−26.7%
    Top 10% of peers

    Higher than 93% of 545 peers

  • 3-month return−20.0%−29.9%

    Higher than 65% of 558 peers

Compared with 592 other US-listed Biotechnology stocks · fundamentals as of Nov 1, 2026 · prices as of Nov 13, 2026

Upcoming events

  • ENLV earnings report

    Consensus EPS estimate −$0.28.

Analyst consensus

Insufficient coverage

0Strong Buy
1Buy
1Neutral
0Sell
0Strong Sell

Based on 2 active firms as of Nov 19, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$80.00
Average$80.00
High$80.00

As of Nov 19, 2026 across 1 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Next earnings

Next: Nov 20, 2026, estimate −$0.28

Smart-money activity

In the last 60 days: 0 insider sales and 0 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.

DateTypeWhoActionAmountSource
Insider buyCRABBE JAMESBuy$44.0KForm 4
Insider buyCRABBE JAMESBuy$69.4KForm 4
Insider buyDUFF STEPHEN MBuy$2.0KForm 4
Insider sellRICE ROBERT ESell$3.3KForm 4
Insider sellRICE ROBERT ESell$6.7KForm 4
Insider sellRICE ROBERT ESell$648Form 4
Insider sellRICE ROBERT ESell$29.1KForm 4
Insider sellRICE ROBERT ESell$10.3KForm 4
Insider sellRICE ROBERT ESell$37.4KForm 4
Insider sellRICE ROBERT ESell$53.7KForm 4
All smart-money activity →

News and press releases

All ENLV news →

Company profile

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis

CEO
Dr. Oren Hershkovitz Ph.D.
Headquarters
Ness Ziona, Israel
Employees
34
IPO date
Dec 12, 1995
Sector
Healthcare
Industry
Biotechnology

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.